| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910495160703321 |
|
|
Autore |
Butera Gianfranco |
|
|
Titolo |
Cardiac Catheterization for Congenital Heart Disease : From Fetal Life to Adulthood |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing AG, , 2021 |
|
©2021 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[2nd ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (1101 pages) |
|
|
|
|
|
|
Altri autori (Persone) |
|
ChessaMassimo |
EickenAndreas |
ThomsonJohn |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Cateterisme cardíac |
Malformacions del cor |
Llibres electrònics |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Intro -- Foreword: "Nothing Endures But Change" -- Preface -- Contents -- Part I: General -- 1: Patient Information and Informed Consent -- 1.1 Introduction -- 1.2 Background -- 1.3 Information and Consent in Clinical Practice -- 1.4 Conclusion -- References -- 2: Anaesthesiological Management of the Paediatric Patient in the Catheterisation Laboratory -- 2.1 Introduction -- 2.2 Anaesthesia -- 2.2.1 Preoperative Consideration -- 2.2.2 Premedication -- 2.2.3 Sedation and Anaesthesia -- 2.3 Monitoring and Anaesthetic Equipment in the Cardiac Catheterisation Laboratory -- 2.3.1 Electrocardiogram -- 2.3.2 Blood Pressure -- 2.3.3 Pulse Oximetry -- 2.3.4 Capnometry -- 2.3.5 Temperature Monitoring -- 2.3.6 ScvO2 (Continuous Mixed Venous Oxygen Saturation) Monitoring -- 2.3.7 NIRS (Near-Infrared Spectroscopy) Monitoring -- 2.3.8 Anaesthetic Equipment -- 2.4 Ventilation Strategies During Cardiac Catheterisation Procedures -- 2.5 Fluid Management -- 2.6 Complications of Cardiac Catheterisation -- Suggested Reading -- 3: Antibiotics and Anticoagulation -- 3.1 Antibiotic Prophylaxis -- 3.2 Anticoagulation in Catheterization Laboratory -- Further Reading -- 4: |
|
|
|
|
|
|
|
|
|
Angiography: Basics and Contrast Media -- 4.1 Cardiac Catheterization Laboratory Equipment Overview and Basic Roentgenology -- 4.2 Tactics for Radiation Dose Reduction and Image Quality Improvement -- 4.2.1 Diagnostic Information Should be Obtained Primarily Noninvasively -- 4.2.2 Position Patients Properly (Isocentered and Straight on the Table) -- 4.2.3 Use the Lowest Acceptable Frame Rate During Pulsed Fluoroscopy and Cine Angiography -- 4.2.4 Do Not Use Fluoroscopy to Make Changes to the Patient/Table Position or Collimator/Shields -- 4.2.5 Remove Unnecessary Body Part (or Instruments) from the Field. |
4.2.6 Always Perform a Test Injection of a Small Amount of Contrast Material Using Fluoroscopy Prior to Acquiring an Angiogram -- 4.2.7 Use the Lowest Acceptable Magnification Mode -- 4.2.8 Use Collimators and Partial-Thickness Shields -- 4.2.9 Center the Region of Interest Correctly in the Field -- 4.2.10 Keep the Image Intensifier as Close to the Patient as Possible (and the X-Ray Tube as Far Away as Possible) -- 4.2.11 Use the Angiographic Projection That Reduces Operator Exposure Whenever Possible -- 4.2.12 Decrease Beam-On Time -- 4.2.13 Remove Anti-Scatter Grids When Catheterizing Small Children -- 4.2.14 Use X-Ray Stand Position Memory -- 4.2.15 Use Biplane Fluoroscopy, Roadmap, and Overlay Features -- 4.2.16 Catheter Selection -- 4.2.17 Contrast Delivery -- 4.3 Contrast Media -- 4.4 Contrast Reactions -- 4.4.1 Anaphylactoid Reactions -- 4.4.2 Nonanaphylactoid Reactions -- 4.4.2.1 Chemotoxic, Organ Specific -- Nephrotoxicity -- Cardiovascular Toxicity -- Neurotoxicity -- Thyroid Dysfunction -- 4.4.2.2 Vasovagal Reactions -- References -- 5: Angiography: Radiation Exposure and Standard Projections -- 5.1 Radiation Exposure Today -- 5.2 Potential Hazards of Radiation Exposure [1] -- 5.2.1 Deterministic Risks -- 5.2.2 Stochastic Risks -- 5.3 Special Problems of Medical Radiation in Children [2] -- 5.4 Terminology [1] -- 5.5 How to Manage Radiation Doses for Invasive Cardiac Procedures [1] -- 5.5.1 Preprocedure -- 5.5.2 Procedure -- 5.5.3 Postprocedure -- 5.6 Angiographic Projections -- 5.7 Specific Lesions (In Situs Solitus with Left Aortic Arch) [3] (Fig. 5.5) -- 5.7.1 Secundum Atrial Septal Defect and Fenestrated Fontan -- 5.7.2 Ventricular Septal Defect -- 5.7.3 Patent Ductus Arteriosus -- 5.7.4 Surgical Fistula Between Supraortic Arch and Branch Pulmonary Artery -- 5.7.5 Aortic Valve. |
5.7.6 Coarctation of the Aorta -- 5.7.7 Mustard Baffle -- 5.7.8 Bidirectional Cavopulmonary Connection -- 5.7.9 Fontan Operation -- 5.7.10 Pulmonary Valve Stenosis, Tetralogy of Fallot, and Pulmonary Valve Atresia with Intact Ventricular Septum -- 5.7.11 Branch Pulmonary Artery Stenosis -- 5.7.12 Total Anomalous Pulmonary Venous Connection -- References -- 6: Catheters and Wires -- 6.1 Diagnostic Catheters -- 6.1.1 Anatomy of the Catheter -- 6.1.2 Types of the Catheters -- 6.1.2.1 Angiographic Catheters -- 6.1.2.2 Pulmonary Balloon Wedge Catheters -- 6.1.2.3 Curved Catheters -- 6.1.2.4 Special Catheter Types -- 6.1.3 Selection of the Catheter and Catheter Manipulation -- 6.1.3.1 Floating Catheters -- 6.1.3.2 Torque-Controlled Catheters -- 6.2 Guidewires -- 6.3 Introducer Sheaths -- Suggested Reading -- 7: Balloons -- 7.1 Introduction -- 7.2 Direct Dilation of Valves and Vessels -- 7.2.1 Characteristics of Balloons -- 7.2.2 Low-Pressure, Medium-Pressure, High-Pressure, and Ultrahigh-Pressure Balloons -- 7.2.3 Cutting Balloons -- 7.2.4 Coronary Balloons -- 7.2.5 Other Special Balloon Dilation Catheters -- 7.3 Septostomy Balloons -- 7.4 Sizing Balloons -- 7.5 How to Use Balloons -- 7.5.1 Preparation, Introduction and Inflation -- 7.5.2 Deflation and Withdrawal -- 7.6 Double-Balloon Technique -- 7.7 |
|
|
|
|
|
|
|
Complications -- 7.8 Basic Requirements -- References -- 8: Stents -- 8.1 Introduction -- 8.2 Indications -- 8.3 Stent Features -- 8.4 Stent Implantation -- 8.5 Complications -- References -- 9: Transcatheter Valve Devices in Congenital Heart Disease -- 9.1 Balloon-Expandable Valves -- 9.1.1 Medtronic Melody Valve -- 9.1.2 Edwards Sapien XT and Sapien 3 Valves -- 9.2 Self-Expanding Valve Replacement Devices -- 9.2.1 Medtronic Harmony Valve -- 9.2.2 Edwards Alterra Adaptive Prestent -- 9.2.3 Venus P Valve. |
9.2.4 Taewong Pulsta Valve -- 9.2.5 Med-Zenith PT-Valve -- References -- 10: "Adult" Tools Relevant for Congenital Heart Disease -- 10.1 Equipment -- 10.1.1 Cardiac Catheters -- 10.1.2 Coronary Wires -- 10.1.2.1 Types of Coronary Guidewires -- 10.1.3 Coronary Balloons -- 10.1.3.1 Types of Coronary Balloons -- 10.1.4 Coronary Stents -- 10.1.4.1 Types of Coronary Stents Most Frequently Used in Congenital Heart Disease -- 10.1.5 Delivery Sheaths -- 10.2 Transcatheter Imaging Tools -- 10.2.1 Fractional Flow Reserve -- 10.2.2 Intracardiac Echocardiography -- Further Reading -- 11: Hemodynamic Assessment: Pressures, Flow, Resistances and Vasoreactive Testing -- 11.1 Hemodynamic Assessment -- 11.2 Pressure Evaluation and Waveforms (Table 11.1) -- 11.3 The Pressures -- 11.3.1 The Right Atrium -- 11.3.2 The Right Ventricle -- 11.3.3 The Pulmonary Artery -- 11.3.4 Pulmonary Capillary Wedge Pressure -- 11.3.5 The Left Atrium -- 11.3.6 The Left Ventricle -- 11.3.7 The Aorta -- 11.4 Assessment of Cardiac Output -- 11.4.1 The Fick Method -- 11.4.2 Indicator-Dilution Method -- 11.4.3 Thermodilution Method -- 11.4.4 Angiographic Method -- 11.5 Assessment of Flows and the Qp:Qs Ratio -- 11.6 Resistance -- 11.7 Pulmonary Vascular Reactivity Testing -- References -- 12: Congenital Heart Disease: An Integrated Care Approach -- 12.1 Introduction -- 12.2 The Importance of Communication in the Relationship Between the Cardiologist and the Patients in the Prenatal and Neonatal Phase -- 12.3 Congenital Heart Disease: Impact on Quality of Life and Psychosocial Aspects for Children and Adolescents -- 12.4 Psychological Functioning in Adults with Congenital Heart Disease -- 12.5 How to Help Families and Patients: Clinical Psychology Service, Patient Associations and Peer-to-Peer Programs -- 12.6 Conclusions -- References. |
Part II: Vascular Access -- 13: The Usual Vascular Access -- 13.1 Femoral Venous and Arterial Access -- 13.1.1 Positioning and Anatomic Landmark Guidance -- 13.1.2 Ultrasound-Guided Puncture -- 13.2 Internal Jugular Vein Access -- 13.2.1 Positioning and Anatomic Landmark Guidance -- 13.2.2 Ultrasound-Guided Puncture -- 13.3 Subclavian Vein Access -- 13.4 Umbilical Venous Access -- 13.4.1 Problems -- 13.5 Radial Artery Access -- 13.5.1 Positioning and Landmarks -- 13.5.2 Technique -- 13.6 Axillary Artery Access -- 13.6.1 Positioning and Landmarks -- 13.6.2 Technique -- References -- 14: Unusual Access -- 14.1 Introduction -- 14.2 Ultrasound-Guided Puncture -- 14.3 Transhepatic Vascular Access -- 14.4 Paravertebral Access -- 14.5 Iliac Venous Access -- References -- 15: Hemostasis -- 15.1 Hemostasis -- 15.1.1 Manual Compression (MC) -- 15.1.2 Vascular Closure Devices (VCD) -- 15.1.2.1 Passive Vascular Closure Devices -- Hemostasis Pads -- Compression Devices: FemoStop (St. Jude Medical, USA) and ClampEase (Pressure Products Inc., USA) -- 15.1.2.2 Active Vascular Closure Devices -- Cardiva Catalyst (Cardiva Medical Inc., USA) -- Collagen Plug Device: Angio-Seal (St. Jude Medical, USA) -- Collagen Plug Device: Mynx (Access Closure, USA) -- Polyglycolic Acid (PGA) Plug Device: ExoSeal (Cordis Corporation, USA) -- FISH (Morris Innovative, USA) -- |
|
|
|
|
|
|
|
|
Clip Device: StarClose (Abbott Vascular, USA) -- Suture Devices: Perclose (Abbott Vascular, USA) -- 15.1.3 Hemostasis in Non-femoral Access Sites -- 15.1.3.1 Jugular Access -- 15.1.3.2 Umbilical Access -- 15.1.3.3 The Transhepatic Access -- 15.1.3.4 Surgical Vascular Access -- 15.1.3.5 Hybrid Procedures -- 15.1.3.6 Fetal Interventions -- References -- 16: Access Complications and Management -- 16.1 Access Complications and Management -- 16.1.1 Preventive Measures. |
16.1.2 Complications Linked to the VAS and Techniques. |
|
|
|
|
|
| |